期刊文献+

七氟醚预处理对体外循环下冠状动脉搭桥术患者心肌保护作用的系统评价 被引量:4

Systematic Review of Cardioprotective Effect of Sevoflurane Preconditioning on Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass
下载PDF
导出
摘要 目的用Meta分析的方法评价七氟醚预处理对体外循环下冠状动脉搭桥术患者的心肌保护作用。方法按照制定的检索策略检索PubMed、EMBASE、中国生物医学数据库等及Cochrane图书馆,文献检索时间为1998-2011年。收集有关七氟醚预处理用于冠状动脉搭桥手术患者的临床随机对照研究,筛选出符合纳入标准的文献,利用RevMan4.2软件对纳入研究结果进行Meta分析。结果共检索到符合条件的文献5篇,包含病例294例。Meta分析结果显示,七氟醚组术后血浆心肌肌钙蛋白T峰值浓度较对照组低(加权均数差为-0.21,95%可信区间为-0.33~-0.09,P<0.05),各研究间存在异质性(P<0.01)。与对照组比较七氟醚组的术后血浆氨基末端脑钠肽前体峰值浓度低、血浆肌酸激酶同工酶浓度低、心脏指数高、不良心血管事件的发生率低。结论七氟醚预处理可对体外循环下冠状动脉搭桥手术患者有明显的心肌保护作用。 Objective To systematically assess the cardioprotective effect of Sevoflurane preconditioning on patients undergoing coronary artery bypass grafting with cardiopulmonary bypass using recta-analysis. Methods Randomized controlled trials of Sevoflurane preconditioning on patients undergoing coronary artery bypass grafting were identified from PubMed, EMBASE, CBMdisc, and Cochrane Library from 1998 to 2011. Data were evaluated and extracted by two reviewers independently with inclusion criteria. Data from randomized controlled trials were entered and analysed with RevMan 4.2 software. Results Five studies that recruited 294 patients were included for meta- analysis. Meta-analysis showed that in Sevoflurane group, postoperative peak cardiac troponin T(cTnT) concentrations was lower than control group [the weighted mean differences (WMD) was -0.21, 95%confidence interval was (-0.33, -0.09), P〈0.05], among these studies there was a significant heterogeneity(P〈0.01). In Sevoflurane group, peak postoperative N-terminal pro-brain natriuretic peptide (NT-ProBNP) concentrations and creatine kinase-MB (CK-MB) activity were lower, cardiac index (CI) were higher, the rate of postoperative adverse cardiac events were lower compared with control group. Conclusions Sevoflurane preconditioning exerts cardioprotective effect on patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
出处 《循证医学》 CSCD 2012年第4期236-240,共5页 The Journal of Evidence-Based Medicine
关键词 冠状动脉分流术 心肺转流术 Meta分析 七氟烷 coronary artery bypass cardiopulmonary bypass meta-analysis Sevoflurane
  • 相关文献

参考文献17

  • 1Krukenkamp IB, Levitsky S. Physiological and cellular mechanisms of myocardial protection [J]. Am J Surg, 1996,172( 1 ) :79-84.
  • 2de Heft SG, ten Broecke PW, Mertens E, et al. Sevoflurane but not propofol preserves myocardial funetin in coronary surgery patients[J] Anesthesiology, 2002,97 ( 1 ) : 42-49.
  • 3Nader ND, Li CM, Khadra WZ, et al. Anesthetic myocardial protection with sevoflurane [J]. J Cardiothorac Vasc Anesth, 2004,18(3) :269-274.
  • 4Kawamura T, Kadosaki M, Nara N, et al. Effects of sevoflurane on cytokine balance in patients undergoing coronary artery bypass graft surgery[J]. J Cardiothorac Vasc Anesth, 2006,20 (4) :503-508.
  • 5Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of repots of randomized clinical trials: Is blinding necessary? [J]. Control Clin Trials, 1996,17(1) : 1-12.
  • 6Bein B, Rennet J, Caliebe D, et al. Tile effects of interrupted or continuous administration of sevoflurane on preconditioning before cardio-pulmonary bypass in coronary artery surgery: Comparison with continuous propofol[J]. Anaesthesia, 2008,63 (7) : 1046-1055.
  • 7Piriou V, Mantz J, Goldfarb G, et al. Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: A randomized bi-centre trial[J]. Br J Anaesth, 2007,99(5) :624- 631.
  • 8于春华,Scott W. Beattie,黄宇光,罗爱伦.七氟醚预处理对体外循环冠状动脉旁路移植术病人围术期心肌的保护作用[J].中华麻醉学杂志,2007,27(6):508-511. 被引量:20
  • 9Garcia C, Juliet K, Bestmann L, et al. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one- year cardiovascular outcome in coronary artery bypass graftsurgery[J]. Br J Anaesth, 2005,94(2) : 159-165.
  • 10Julier K, da Silva R, Garcia C, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: A double-blinded, placebo-controlled, muhicenter study [J]. Anesthesiology, 2003,98(6) : 1315-1327.

二级参考文献20

  • 1Yu CH, Beattie WS. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anaesth, 2006, 53: 906-918.
  • 2De Hert SG, Cromheecke S, ten Broecke PW, et al. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology, 2003, 99: 314-323.
  • 3De Hert SG, ten Broecke PW, Mertens E, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients.Anesthesiology, 2002, 97: 42-49.
  • 4De Hert SG, Van der Linden PJ, Cromheecke S, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology, 2004, 101 : 9-20.
  • 5De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Auestheslology,2004,101 : 299-310.
  • 6El Azab SR, Scheffer GJ, Rosseel PM, et al. Induction and maintenance of anaesthesia with sevoflurane in comparison to high dose opioid during coronary artery bypass surgery. Eur J Anaesthesiol, 2000, 17: 336-338.
  • 7Conzen PF, Fischer S, Detter C, et al. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology, 2003, 99: 826-833.
  • 8Garela C, Juller K, Bestmann L, et al. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth, 2005, 94: 159-165.
  • 9Nader ND, Li CM, Khadra WZ, et al. Anesthetic myocardial protection with sevoflurane. J Cardiothorac Vasc Anesth, 2004, 18 : 269-274.
  • 10Julier K, da Silva R, Garcia C, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebocontrolled, multicenter study. Anesthesiology, 2003, 98 : 1315-1327.

共引文献89

同被引文献82

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部